These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6253302)

  • 1. Continuing studies of feline sarcoma virus induced tumors in newborn lambs and in kittens: a model to study comparative neoplasia.
    Anderson BC; Theilen GH
    Eur J Cancer (1965); 1980 Jul; 16(7):925-35. PubMed ID: 6253302
    [No Abstract]   [Full Text] [Related]  

  • 2. Feline uveal melanoma model induced with feline sarcoma virus.
    Albert DM; Shadduck JA; Craft JL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1981 May; 20(5):606-24. PubMed ID: 6260703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological studies of tumors induced in sheep by injecting ovine cells transformed in vitro with feline sarcoma virus.
    Theilen GH; Pedersen NC; Hall JG
    Bibl Haematol; 1975 Oct; (43):380-3. PubMed ID: 183703
    [No Abstract]   [Full Text] [Related]  

  • 4. The nature of immunity to Snyder-Theilen fibrosarcoma virus induced tumors in cats.
    Johnson L; Pedersen NC; Theilen GH
    Vet Immunol Immunopathol; 1985 Jul; 9(3):283-300. PubMed ID: 2994282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
    Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
    Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer cells of feline leukemia virus- and feline sarcoma virus-infected transformed cells: the role of NK, ADCC, and in vitro generated cytotoxic cells.
    Kooistra LH; Splitter GA
    Cell Immunol; 1985 Sep; 94(2):466-79. PubMed ID: 2992811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enucleation and the appearance of second primary tumors in cats bearing virally induced intraocular tumors.
    Niederkorn JY; Shadduck JA; Albert D
    Invest Ophthalmol Vis Sci; 1982 Dec; 23(6):719-25. PubMed ID: 6292123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regional and distant lymph nodes in rejection of feline sarcoma virus-induced tumors in sheep.
    Thellen GH; Pedersen NC; Higgins J
    J Natl Cancer Inst; 1979 Aug; 63(2):389-400. PubMed ID: 222930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active and passive immunization of cats with inactivated feline oncornaviruses.
    Schaller JP; Hoover EA; Olsen RG
    J Natl Cancer Inst; 1977 Nov; 59(5):1441-50. PubMed ID: 198563
    [No Abstract]   [Full Text] [Related]  

  • 10. Feline sarcoma virus-specific transformation-related proteins and protein kinase activity in tumor cells.
    Chen AP; Essex M; Kelliher M; de Noronha F; Shadduck JA; Niederkorn JY; Albert D
    Virology; 1983 Jan; 124(2):274-85. PubMed ID: 6186075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization against feline oncarnavirus disease using a killed tumor cell vaccine.
    Olsen RG; Hoover EA; Mathes LE; Heding L; Schaller JP
    Cancer Res; 1976 Oct; 36(10):3642-6. PubMed ID: 182360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies against feline oncornavirus-associated cell membrane antigen in cats bearing virally induced uveal melanomas.
    Niederkorn JY; Shadduck JA; Albert D; Essex M
    Invest Ophthalmol Vis Sci; 1981 May; 20(5):598-605. PubMed ID: 6260702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat.
    Bachman D; Cockerell GL; de Noronha F; Rapp HJ
    Am J Vet Res; 1982 Mar; 43(3):475-80. PubMed ID: 6280529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic immune response of puppies to feline sarcoma virus induced tumors.
    Suter MM; Osburn BI; Holmberg CA
    Vet Immunol Immunopathol; 1984 Sep; 7(2):131-8. PubMed ID: 6093343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on FeSV induced sarcomata in sheep with particular reference to the regional lymphatic system.
    Hall JG; Scollay RG; Birbeck MS; Theilen GH
    Br J Cancer; 1975 Dec; 32(6):639-59. PubMed ID: 175813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
    McCarty JM; Grant CK
    Cell Immunol; 1983 Oct; 81(1):157-68. PubMed ID: 6311439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new tumor model for angiographic investigations: feline sarcoma virus tumor induction in adult cats.
    Reid MH
    Invest Radiol; 1980; 15(2):140-4. PubMed ID: 6246023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline uveal melanomas induced with feline sarcoma virus: potential model of the human counterpart.
    Shadduck JA; Albert DM; Niederkorn JY
    J Natl Cancer Inst; 1981 Sep; 67(3):619-27. PubMed ID: 6268880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.